nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Malnutrition—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Goserelin—Cough—Bleomycin—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Goserelin—Angiopathy—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Goserelin—Diarrhoea—Teniposide—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Goserelin—Myalgia—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Goserelin—Chest pain—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Goserelin—Alopecia—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Goserelin—Back pain—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Goserelin—Discomfort—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Mental disorder—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Chills—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Neoplasm—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Bladder pain—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Ecchymosis—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Goserelin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Goserelin—Alopecia—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Goserelin—Confusional state—Bleomycin—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Goserelin—Vision blurred—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Goserelin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Goserelin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Goserelin—Oedema—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Goserelin—Erythema—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Goserelin—Infection—Bleomycin—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Goserelin—Anaemia—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Goserelin—Back pain—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Goserelin—Vomiting—Teniposide—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Sepsis—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Goserelin—Asthenia—Fludarabine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Goserelin—Rash—Teniposide—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Goserelin—Dermatitis—Teniposide—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Goserelin—Headache—Teniposide—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Goserelin—Pruritus—Fludarabine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Goserelin—Back pain—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Goserelin—Leukopenia—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Goserelin—Anorexia—Bleomycin—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Goserelin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Goserelin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Goserelin—Anaemia—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Goserelin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Goserelin—Hypotension—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Goserelin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Goserelin—Convulsion—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Goserelin—Hypertension—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Goserelin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Goserelin—Nausea—Teniposide—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Goserelin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Goserelin—Leukopenia—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Myalgia—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Chest pain—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Anxiety—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Goserelin—Malaise—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Goserelin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Goserelin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Goserelin—Convulsion—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Goserelin—Hypertension—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Goserelin—Confusional state—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Goserelin—Oedema—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Goserelin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Goserelin—Myalgia—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Goserelin—Cough—Mitoxantrone—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Goserelin—Infection—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Goserelin—Vomiting—Fludarabine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Goserelin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Rash—Fludarabine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Dermatitis—Fludarabine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Hypertension—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Pain—Bleomycin—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Headache—Fludarabine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Tachycardia—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Goserelin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Chest pain—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Anxiety—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Goserelin—Lethargy—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Goserelin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Goserelin—Oedema—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Goserelin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Goserelin—Anorexia—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Goserelin—Infection—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Goserelin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Nervous system disorder—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Hypotension—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Oedema—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Nausea—Fludarabine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Infection—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Goserelin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Goserelin—Shock—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Goserelin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Urticaria—Bleomycin—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Anorexia—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Insomnia—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Goserelin—Paraesthesia—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Goserelin—Mood swings—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Hypotension—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Dyspnoea—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Somnolence—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Anorexia—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Goserelin—Decreased appetite—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Goserelin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Goserelin—Insomnia—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Goserelin—Paraesthesia—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Goserelin—Pain—Carmustine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Goserelin—Constipation—Carmustine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Goserelin—Breast disorder—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Goserelin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000996	0.000996	CcSEcCtD
Goserelin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000985	0.000985	CcSEcCtD
Goserelin—Decreased appetite—Vincristine—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Goserelin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Goserelin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Goserelin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Goserelin—Fatigue—Vincristine—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Goserelin—Asthenia—Bleomycin—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Goserelin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Goserelin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Goserelin—Constipation—Vincristine—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Goserelin—Pain—Vincristine—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Goserelin—Pruritus—Bleomycin—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Goserelin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Goserelin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Goserelin—Constipation—Mitoxantrone—lymphatic system cancer	0.000938	0.000938	CcSEcCtD
Goserelin—Pain—Mitoxantrone—lymphatic system cancer	0.000938	0.000938	CcSEcCtD
Goserelin—Body temperature increased—Carmustine—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Goserelin—Abdominal pain—Carmustine—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Goserelin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Goserelin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Goserelin—Dysuria—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Goserelin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Goserelin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Goserelin—Abdominal pain—Vincristine—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Goserelin—Body temperature increased—Vincristine—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Goserelin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000885	0.000885	CcSEcCtD
Goserelin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Goserelin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Goserelin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000869	0.000869	CcSEcCtD
Goserelin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000867	0.000867	CcSEcCtD
Goserelin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000867	0.000867	CcSEcCtD
Goserelin—Pneumonia—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Goserelin—Vomiting—Bleomycin—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Goserelin—Drowsiness—Methotrexate—lymphatic system cancer	0.000857	0.000857	CcSEcCtD
Goserelin—Depression—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Goserelin—Rash—Bleomycin—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Goserelin—Dermatitis—Bleomycin—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Goserelin—Asthenia—Carmustine—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Goserelin—Renal failure—Methotrexate—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Goserelin—Hypersensitivity—Vincristine—lymphatic system cancer	0.00083	0.00083	CcSEcCtD
Goserelin—Sweating—Methotrexate—lymphatic system cancer	0.000822	0.000822	CcSEcCtD
Goserelin—Haematuria—Methotrexate—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Goserelin—Epistaxis—Methotrexate—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Goserelin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Goserelin—Asthenia—Vincristine—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Goserelin—Diarrhoea—Carmustine—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Goserelin—Nausea—Bleomycin—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Goserelin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Goserelin—Dizziness—Carmustine—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Goserelin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Goserelin—Diarrhoea—Vincristine—lymphatic system cancer	0.000771	0.000771	CcSEcCtD
Goserelin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000769	0.000769	CcSEcCtD
Goserelin—Hepatitis—Methotrexate—lymphatic system cancer	0.000769	0.000769	CcSEcCtD
Goserelin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00076	0.00076	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Goserelin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000751	0.000751	CcSEcCtD
Goserelin—Vomiting—Carmustine—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Goserelin—Dizziness—Vincristine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Goserelin—Rash—Carmustine—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Goserelin—Dermatitis—Carmustine—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Goserelin—Headache—Carmustine—lymphatic system cancer	0.000739	0.000739	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Goserelin—Vomiting—Vincristine—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000714	0.000714	CcSEcCtD
Goserelin—Rash—Vincristine—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Goserelin—Dermatitis—Vincristine—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Goserelin—Headache—Vincristine—lymphatic system cancer	0.000706	0.000706	CcSEcCtD
Goserelin—Nausea—Carmustine—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Goserelin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Goserelin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Goserelin—Rash—Mitoxantrone—lymphatic system cancer	0.000692	0.000692	CcSEcCtD
Goserelin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Goserelin—Chills—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Goserelin—Headache—Mitoxantrone—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Goserelin—Alopecia—Methotrexate—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
Goserelin—Erythema—Methotrexate—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
Goserelin—Nausea—Vincristine—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Goserelin—Nausea—Mitoxantrone—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Goserelin—Back pain—Methotrexate—lymphatic system cancer	0.000648	0.000648	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—lymphatic system cancer	0.000631	0.000631	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Goserelin—Anaemia—Methotrexate—lymphatic system cancer	0.000619	0.000619	CcSEcCtD
Goserelin—Malaise—Methotrexate—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Goserelin—Leukopenia—Methotrexate—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Goserelin—Cough—Methotrexate—lymphatic system cancer	0.000584	0.000584	CcSEcCtD
Goserelin—Convulsion—Methotrexate—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Goserelin—Myalgia—Methotrexate—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Goserelin—Chest pain—Methotrexate—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000566	0.000566	CcSEcCtD
Goserelin—Discomfort—Methotrexate—lymphatic system cancer	0.000563	0.000563	CcSEcCtD
Goserelin—Confusional state—Methotrexate—lymphatic system cancer	0.000551	0.000551	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Goserelin—Infection—Methotrexate—lymphatic system cancer	0.000543	0.000543	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000536	0.000536	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000535	0.000535	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—lymphatic system cancer	0.000531	0.000531	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000528	0.000528	CcSEcCtD
Goserelin—Anorexia—Methotrexate—lymphatic system cancer	0.000521	0.000521	CcSEcCtD
Goserelin—Hypotension—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000498	0.000498	CcSEcCtD
Goserelin—Insomnia—Methotrexate—lymphatic system cancer	0.000494	0.000494	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000491	0.000491	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000487	0.000487	CcSEcCtD
Goserelin—Somnolence—Methotrexate—lymphatic system cancer	0.000486	0.000486	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000481	0.000481	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
Goserelin—Fatigue—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Goserelin—Pain—Methotrexate—lymphatic system cancer	0.000467	0.000467	CcSEcCtD
Goserelin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00045	0.00045	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000447	0.000447	CcSEcCtD
Goserelin—Urticaria—Methotrexate—lymphatic system cancer	0.000434	0.000434	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000432	0.000432	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000432	0.000432	CcSEcCtD
Goserelin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000403	0.000403	CcSEcCtD
Goserelin—Asthenia—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Goserelin—Pruritus—Methotrexate—lymphatic system cancer	0.000387	0.000387	CcSEcCtD
Goserelin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000374	0.000374	CcSEcCtD
Goserelin—Dizziness—Methotrexate—lymphatic system cancer	0.000361	0.000361	CcSEcCtD
Goserelin—Vomiting—Methotrexate—lymphatic system cancer	0.000348	0.000348	CcSEcCtD
Goserelin—Rash—Methotrexate—lymphatic system cancer	0.000345	0.000345	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—lymphatic system cancer	0.000344	0.000344	CcSEcCtD
Goserelin—Headache—Methotrexate—lymphatic system cancer	0.000342	0.000342	CcSEcCtD
Goserelin—Nausea—Methotrexate—lymphatic system cancer	0.000325	0.000325	CcSEcCtD
